Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Innate Immun ; 25(1): 3-12, 2019 01.
Article in English | MEDLINE | ID: mdl-30426809

ABSTRACT

Pseudomonas aeruginosa-derived pigment pyocyanin (PCN) has been proved to induce cell apoptosis mediated by the generation of reactive oxygen species (ROS), which has been studied mainly in epithelial cells and neutrophils. However, we previously found that the PCN-producing strain PA14 induces cell apoptosis in human NK cell line NK92 more effectively than in PCN-deficient strain PA14-phZ1/2 via a yet undetermined mechanism. In the current study, we found that PCN-induced NK92 cell apoptosis occurs through mitochondrial damage despite inhibiting intracellular ROS generation. Intracellular Ca2+ ([Ca2+]i) and Bcl-2 family proteins act as important "priming signals" for apoptosis. PCN treatment increased [Ca2+]i in NK92 cells more than twofold after 2 h stimulation, whereas the Ca2+-chelating agent ethylene glycol tetra-acetic acid (EGTA) inhibited apoptosis. PCN triggered the activation of Bim, Bid, Bik, Bak, and phospho-Bad in NK92 cells in a concentration-dependent manner, but these pro-apoptotic Bcl-2 family proteins were not inhibited by EGTA. In this study, we describe the function of PCN in NK92 cells and identify mitochondrial damage as the mechanism underlying the apoptosis. [Ca2+]i and pro-apoptotic Bcl-2 family proteins are novel targets for PCN-induced apoptosis. Clarification of the cytotoxic diversity of PCN provides a new therapeutic target for defense from P. aeruginosa-induced immune cell damage.


Subject(s)
Killer Cells, Natural/physiology , Mitochondria/metabolism , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/physiology , Pyocyanine/metabolism , Apoptosis , Calcium/metabolism , Cell Line , Egtazic Acid/pharmacology , Humans , Intracellular Space , Oxidative Stress , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/metabolism
2.
Mol Ther Nucleic Acids ; 8: 111-122, 2017 Sep 15.
Article in English | MEDLINE | ID: mdl-28918013

ABSTRACT

Cancer stem cells (CSCs) play an important role in osteosarcoma (OS) metastasis and recurrence, and both Wnt/ß-catenin and Notch signaling are essential for the development of the biological traits of CSCs. However, the mechanism that underlies the simultaneous hyperactivation of both Wnt/ß-catenin and Notch signaling in OS remains unclear. Here, we report that expression of miR-135b correlates with the overall and recurrence-free survival of OS patients, and that miR-135b has an activating effect on both Wnt/ß-catenin and Notch signaling. The overexpression of miR-135b simultaneously targets multiple negative regulators of the Wnt/ß-catenin and Notch signaling pathways, including glycogen synthase kinase-3 beta (GSK3ß), casein kinase 1a (CK1α), and ten-eleven translocation 3 (TET3). Therefore, upregulated miR-135b promotes CSC traits, lung metastasis, and tumor recurrence in OS. Notably, antagonizing miR-135b potently inhibits OS lung metastasis, cancer cell stemness, CSC-induced tumor formation, and recurrence in xenograft animal models. These findings suggest that miR-135b mediates the constitutive activation of Wnt/ß-catenin and Notch signaling, and that the inhibition of miR-135b is a novel strategy to inhibit tumor metastasis and prevent CSC-induced recurrence in OS.

3.
Cell Immunol ; 318: 23-28, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28601359

ABSTRACT

Osteopontin (OPN) is a multifunctional protein involved in various pathophysiological processes. However, the role of OPN in Pseudomonas aeruginosa-related sepsis is not yet clear. Here, we found that OPN expression was elevated in plasma and spleen samples from P. aeruginosa-infected mice. To determine the function of OPN in sepsis, we used wild-type (WT) and OPN-knockout (KO) mice with P. aeruginosa-induced bacteremia. We found that OPN-KO mice exhibited reduced mortality compared with WT mice and that OPN exacerbated spleen bleeding and functional impairment. OPN-KO mice exhibited reduced secretion of pro-inflammatory cytokines, such as interferon-γ, interleukin (IL)-1ß, IL-12, and tumor necrosis factor-α, whereas levels of anti-inflammatory cytokine IL-10 and the leukocyte trafficking mediator macrophage inflammatory protein (MIP)-2 were not altered. Additionally, the percentages and absolute numbers of B cells were elevated in the spleens of OPN-KO mice. Thus, OPN promoted sepsis in P. aeruginosa-infected mice and potentially blocked B cell-dependent immunity.


Subject(s)
B-Lymphocytes/immunology , Bacteremia/immunology , Osteopontin/metabolism , Pseudomonas Infections/immunology , Pseudomonas aeruginosa/immunology , Spleen/physiology , Animals , Bacterial Load , Cells, Cultured , Cytokines/metabolism , Humans , Inflammation Mediators/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Osteopontin/genetics
4.
Mol Ther ; 25(9): 2140-2149, 2017 09 06.
Article in English | MEDLINE | ID: mdl-28648665

ABSTRACT

Dysregulated microRNAs (miRNAs) play an important role in osteosarcoma (OS) progression. In the present study, we investigate the clinical significance of serum miR-491 level and the potential role of miR-491 in OS lung metastasis and chemoresistance. Clinical data show that the level of miR-491 was decreased in serum from OS patients compared with healthy control subjects, and that a decreased serum miR-491 level is correlated with increased metastasis, poor chemoresponse, and lower survival rate in OS patients. In vitro and in vivo experiments show that overexpression of miR-491 suppresses OS cell lung metastasis, whereas it enhances cisplatin (CDDP)-induced tumor growth inhibition and apoptosis. In contrast, inhibition of miR-491 stimulates OS cell lung metastasis and suppresses CDDP-induced tumor growth inhibition and apoptosis. Furthermore, we demonstrate that miR-491 exerts its role by directly targeting αB-crystallin (CRYAB) in OS. Our findings suggest that serum level of miR-491 has potential as a biomarker for predicting OS progression and prognosis of OS patients. Additionally, restoration of miR-491 may be a novel strategy for inhibiting OS lung metastasis and overcoming OS cell resistance to chemotherapy.


Subject(s)
Bone Neoplasms/genetics , Bone Neoplasms/pathology , Drug Resistance, Neoplasm/genetics , Lung Neoplasms/secondary , MicroRNAs/genetics , Osteosarcoma/genetics , Osteosarcoma/pathology , alpha-Crystallin B Chain/genetics , Apoptosis , Bone Neoplasms/drug therapy , Bone Neoplasms/mortality , Cell Line, Tumor , Cell Proliferation , Circulating MicroRNA , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/blood , Neoplasm Metastasis , Neoplasm Staging , Osteosarcoma/drug therapy , Osteosarcoma/mortality , Prognosis , RNA Interference
5.
Chin J Nat Med ; 15(4): 281-287, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28527513

ABSTRACT

The present study was designed to perform structural modifications of of neobavaisoflavone (NBIF), using an in vitro enzymatic glycosylation reaction, in order to improve its water-solubility. Two novel glucosides of NBIF were obtained from an enzymatic glycosylation by UDP-glycosyltransferase. The glycosylated products were elucidated by LC-MS, HR-ESI-MS, and NMR analysis. The HPLC peaks were integrated and the concentrations in sample solutions were calculated. The MTT assay was used to detect the cytotoxic activity of compounds in cancer cell lines. Based on the spectroscopic analyses, the two novel glucosides were identified as neobavaisoflavone-4'-O-ß-D-glucopyranoside (1) and neobavaisoflavone-4', 7-di-O-ß-D-glucopyranoside (2). Additionally, the water-solubilities of compounds 1 and 2 were approximately 175.1- and 4 031.9-fold higher than that of the substrate, respectively. Among the test compounds, only NBIF exhibited weak cytotoxicity against four human cancer cell lines, with IC50 values ranging from 63.47 to 72.81 µmol·L-1. These results suggest that in vitro enzymatic glycosylation is a powerful approach to structural modification, improving water-solubility.


Subject(s)
Glucosides/biosynthesis , Glycosyltransferases/metabolism , Isoflavones/biosynthesis , Antineoplastic Agents/metabolism , Antineoplastic Agents/pharmacology , Bacillus/enzymology , Cell Line, Tumor , Colorimetry , Drug Screening Assays, Antitumor , Glucosides/chemistry , Humans , Isoflavones/chemistry , Molecular Structure , Solubility
6.
Inflammation ; 40(3): 735-744, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28181039

ABSTRACT

Pseudomonas aeruginosa is the major cause of morbidity and mortality in patients with ventilator-associated pneumonia. Interferon regulatory factor 3 (IRF3) is a transcription factor that plays an important role in the immune response to viral infection via the IRF3/IFN-ß signaling pathway. Controversial data exist regarding the role of IRF3 in immune cell recruitment during bacterial infections. IRF3 has been shown to promote neutrophil recruitment and bacterial clearance in mice infected with P. aeruginosa by inducing the production of specific chemokines and cytokines. In contrast, our study showed that IRF3 knockout (KO) mice infected with P. aeruginosa exhibited greater survival rates, demonstrated enhanced bacterial clearance, and showed significantly increased neutrophil recruitment to the lungs, when compared with the wild-type (WT) mice. The peritoneal lavage fluid collected from IRF3 KO mice 4 h after intraperitoneal injection with P. aeruginosa or 3% thioglycolate contained a significantly increased number of neutrophils. Furthermore, neutrophils from the bone marrow (BM) of IRF3 KO mice showed greater adhesiveness to the extracellular matrix when compared with those of WT mice, post-P. aeruginosa infection. In addition, IRF3 induced the expression of target genes in WT neutrophils infected with P. aeruginosa. These findings indicate that IRF3 exacerbates P. aeruginosa-induced mortality in mice by inhibiting neutrophil adhesion and recruitment to the lungs. Together, these data indicate that the inhibition of IRF3 might provide a possible mechanism for controlling P. aeruginosa infections.


Subject(s)
Interferon Regulatory Factor-3/immunology , Neutrophil Infiltration/drug effects , Neutrophils/pathology , Animals , Cell Adhesion/drug effects , Extracellular Matrix/metabolism , Interferon Regulatory Factor-3/pharmacology , Mice , Mice, Knockout , Pseudomonas Infections/drug therapy , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa
7.
J Infect Dis ; 208(3): 528-38, 2013 Aug 01.
Article in English | MEDLINE | ID: mdl-23613163

ABSTRACT

Macrophage polarization is critical for dictating host defense against pathogens and injurious agents. Dysregulation of macrophage differentiation has been implicated in infectious and inflammatory diseases. Here, we show that protein kinase B/Akt1 signaling induced by Staphylococcus aureus is essential in shifting macrophages from an antimicrobial phenotype (M1) to a functionally inert signature. Akt1(-/-)mice consistently had enhanced bacterial clearance and greater survival, compared with their wild-type littermates. The blunted M1 macrophage reaction driven by Akt1 was associated with decreased RelA/nuclear factor κB activity. Furthermore, by repression of the expression of suppressor of cytokine signaling 1 (SOCS1), microRNA 155 revealed to promote the transcription of M1 signature genes in macrophages from Akt1(-/-) mice. Accordingly, blocking of microRNA 155 in macrophages from Akt1(-/-)mice or knockdown of SOCS1 in cells from wild-type mice disabled or enabled, respectively, an M1 macrophage shift and antibacterial response. These results thus establish an Akt1-mediated, microRNA-involved circuit that regulates pathogen-driven macrophage polarization and, subsequently, the host response to infection.


Subject(s)
Macrophages/immunology , Pneumonia, Staphylococcal/immunology , Proto-Oncogene Proteins c-akt/metabolism , Staphylococcus aureus/immunology , Animals , Disease Models, Animal , Mice , Mice, Knockout , Signal Transduction
8.
Cell Immunol ; 280(1): 1-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23246829

ABSTRACT

Vitamin-D3 upregulated protein-1 (VDUP1) is a stress response protein. Pseudomonas aeruginosa (P. aeruginosa) infection is a leading cause of death. Mice infected with live P. aeruginosa exhibit significantly decreased VDUP1 expression. However, the function of VDUP1 during P. aeruginosa-induced mouse bacteremic shock is unknown. To address the function of VDUP1 in P. aeruginosa-infected mice, we constructed a bacteremic shock model wherein both wild-type and VDUP1-deficient mice were infected intra-peritoneally with live P. aeruginosa. We found that VDUP1-deficient mice were more resistant to P. aeruginosa-induced bacteremic shock than wild-type mice, as shown by the increased survival, accelerated bacterial clearance and suppression of cytokine overproduction of the VDUP1-deficient mice. VDUP1 promoted the recruitment of neutrophils into the peritoneal cavities of infected mice. VDUP1 impeded the phagocytosis of non-opsonized P. aeruginosa via phosphatidylinositide 3-kinase (PI3K) pathway in macrophages. P. aeruginosa infection induced the generation of reactive oxygen species (ROS), and the increased production of ROS by the peritoneal cells of VDUP1-deficient mice was advantageous in clearing the bacteria. Overall, VDUP1 aggravates bacteremic shock; thus, VDUP1 can be considered a target molecule for the inhibition of P. aeruginosa-induced bacteremic shock.


Subject(s)
Carrier Proteins/physiology , Peritonitis/physiopathology , Pseudomonas Infections/physiopathology , Shock, Septic/physiopathology , Thioredoxins/physiology , Animals , Apoptosis/physiology , Carrier Proteins/genetics , Chemotaxis, Leukocyte/physiology , Colony Count, Microbial , Cytokines/biosynthesis , Mice , Mice, Inbred C57BL , Mice, Knockout , Neutrophils/pathology , Peritoneal Cavity/microbiology , Peritoneal Cavity/pathology , Peritonitis/microbiology , Phagocytosis/physiology , Phosphatidylinositol 3-Kinases/physiology , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/isolation & purification , Reactive Oxygen Species/metabolism , Signal Transduction/physiology , Specific Pathogen-Free Organisms , Spleen/microbiology , Thioredoxins/genetics
9.
Mol Cells ; 34(6): 555-61, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23161172

ABSTRACT

Olfactomedin 4 (OLFM4) is highly expressed in gastrointestinal cancers and has an anti-apoptotic function. The roles of OLFM4 in tumor growth and metastasis and how it functions in these processes remain elusive. We investigated the function of OLFM4 in tumor growth and metastasis using B16F10 mouse melanoma cells as an experimental system. Our results showed that OLFM4 had no positive effect on cell viability or cell cycle progression in B16F10 cells. However, it significantly suppressed the tumorigenicity of B16F10 cells, i.e., intradermal primary tumor growth and lung metastasis. OLFM4 also suppressed the migration and invasion of B16F10 cells in vitro. For further insight into the mechanisms underlying OLFM4-mediated suppression of tumor progression, we examined the effect of OLFM4 on the expression of integrin and matrix metalloproteinase (MMP), both of which are involved in tumor progression. Overexpression of OLFM4 clearly reduced the expression levels of integrin α1, integrin α4, integrin α5, integrin α6, and MMP9. Moreover, forced expression of MMP9 attenuated the inhibitory activity of OLFM4 on migration and invasiveness. Our findings provide the experimental evidence that OLFM4 may function as a tumor suppressor and an anti-metastatic gene during tumor progression.


Subject(s)
Down-Regulation , Extracellular Matrix Proteins/metabolism , Glycoproteins/metabolism , Integrins/genetics , Matrix Metalloproteinase 9/genetics , Melanoma, Experimental/metabolism , Animals , Cell Survival , Humans , Integrin alpha1/genetics , Integrin alpha1/metabolism , Integrin alpha6/genetics , Integrin alpha6/metabolism , Integrins/metabolism , Matrix Metalloproteinase 9/metabolism , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Neoplasm Metastasis , Tumor Cells, Cultured
10.
Immunol Lett ; 141(1): 61-7, 2011 Dec 30.
Article in English | MEDLINE | ID: mdl-21835206

ABSTRACT

The IL-22 NKp46(+) innate lymphoid cells, NCR22 cells, are very important for the early host defense against microbial pathogens. We show here that NCR22 cells were differentiated from Lin(-)CD127(+)CD117(+) cells that were derived from hematopoietic precursor cells (HPCs) of mouse bone marrow cells. The combination of low concentrations of IL-23 and IL-15 induced differentiation of NCR22 cells from Lin(-)CD127(+)CD117(+) cells. NCR22 cells expressed a large amount of IL-22 and RORγt, and they had poor cytolytic activity and produced little IFN-γ. Lin(-)CD127(+)CD117(+) cells were very similar to intestinal lamina propria LTi-like cells; both cells dominantly expressed RORγt and IL-22. Meanwhile, Lin(-)CD127(-)CD117(+) cells that were also derived from HPCs did not express RORγt and IL-22, and they developed into conventional NK cells, not into NCR22 cells. These findings revealed that NCR22 cells can be differentiated from Lin(-)CD127(+)CD117(+) cells which are derived from HPCs.


Subject(s)
Antigens, Ly/metabolism , Cell Differentiation/physiology , Interleukins/biosynthesis , Killer Cells, Natural , Natural Cytotoxicity Triggering Receptor 1/metabolism , Nuclear Receptor Subfamily 1, Group F, Member 3/biosynthesis , Animals , Female , Hematopoietic Stem Cells/metabolism , Interleukin-15/immunology , Interleukin-15/metabolism , Interleukin-23/metabolism , Interleukin-7 Receptor alpha Subunit/metabolism , Intestinal Mucosa/metabolism , Killer Cells, Natural/cytology , Killer Cells, Natural/metabolism , Lymphocytes/metabolism , Mice , Mice, Inbred Strains , Mice, Knockout , Proto-Oncogene Proteins c-kit/metabolism , Interleukin-22
11.
Immunol Lett ; 136(1): 29-36, 2011 Apr 30.
Article in English | MEDLINE | ID: mdl-21126536

ABSTRACT

Natural killer (NK) cells act important roles in innate immunity and adaptive immunity. However, the mechanisms governing NK cell development have not been clearly elucidated. Previous studies have shown that an HMG (high-mobility group) protein, TOX, is important for regulating the differentiation program of developing T cells in mice. In this study, we examined the role of TOX in differentiation of human NK cells. Knockdown of TOX in differentiating cells decreased the NK cell population identified by expression of NK surface markers and receptors. In addition, over-expression of TOX enhanced the differentiation of NK cells which give rise to a population showing effector functions of mature NK cells. Moreover, TOX influenced expression of T-bet (T-box expressed in T cells, also as known as Tbx21) during NK cell development. Overall, these results suggest that TOX is required for IL-15-mediated NK cell differentiation and affected expression of T-bet that plays critical roles in NK differentiation and maturation.


Subject(s)
Cell Differentiation , Hematopoietic Stem Cells/immunology , High Mobility Group Proteins/immunology , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Gene Expression Regulation , Hematopoietic Stem Cells/cytology , High Mobility Group Proteins/genetics , Humans , K562 Cells , RNA, Small Interfering/genetics , Transcription, Genetic
12.
J Immunol ; 185(2): 917-28, 2010 Jul 15.
Article in English | MEDLINE | ID: mdl-20543098

ABSTRACT

NK cells are capable of killing virus-infected or tumor cells and producing IFN-gamma. Resting NK cells, however, have only minimal cytolytic activity and secrete a low level of IFN-gamma. The cytokine IL-15 can promote the expression of effector functions by resting NK cells. In this study, we demonstrate that suppressor of cytokine signaling 2 (SOCS2) has a novel role in IL-15-primed human NK cell function. SOCS2 expression was upregulated in NK cells following stimulation with IL-15. During IL-15-mediated NK cell priming, SOCS2 interacted with phosphorylated proline-rich tyrosine kinase 2 (Pyk2) at tyrosine 402 (p-Pyk2(Tyr402)) and induced the proteasome-mediated degradation of p-Pyk2(Tyr402) via ubiquitination. Knockdown of SOCS2 resulted in the accumulation of p-Pyk2(Tyr402) and blocked NK cell effector functions. In addition, NK cell cytolytic activity and IFN-gamma production were inhibited by overexpression of the wild-type of Pyk2 but not by the overexpression of tyrosine 402 mutant of Pyk2. These results suggest that SOCS2 regulates human NK cell effector functions via control of phosphorylated Pyk2 depending on IL-15 existence.


Subject(s)
Focal Adhesion Kinase 2/metabolism , Interleukin-15/pharmacology , Killer Cells, Natural/drug effects , Suppressor of Cytokine Signaling Proteins/metabolism , Blotting, Western , Cell Differentiation/drug effects , Cell Line , Cell Line, Tumor , Cell Survival/drug effects , Cells, Cultured , Cytotoxicity, Immunologic/drug effects , Cytotoxicity, Immunologic/immunology , Focal Adhesion Kinase 2/genetics , Humans , Infant, Newborn , Interferon-gamma/metabolism , Jurkat Cells , K562 Cells , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Mutation , Phosphorylation/drug effects , Protein Binding , RNA Interference , Receptors, Interleukin-15/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Suppressor of Cytokine Signaling Proteins/genetics , Tyrosine/metabolism
13.
Int Immunopharmacol ; 10(4): 481-6, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20116458

ABSTRACT

NK cells play crucial roles in innate immunity and adaptive immunity. The detailed mechanisms, however, governing NK cell development remains unclear. In this study, we report that YC-1 significantly enhances NK cell populations differentiated from human umbilical cord blood hematopoietic stem cells (HSCs). NK cells increased by YC-1 display both phenotypic and functional features of fully mature NK (mNK) cells, but YC-1 does not affect the activation of mNK cells. YC-1 did not affect cGMP production and phosphorylation of STAT-5 which is essential for IL-15R signaling. On the other hand, YC-1 increased p38 MAPK phosphorylation during NK cell differentiation. Furthermore, p38 inhibitor SB203580 inhibited the differentiation of NK cells enhanced by YC-1. Taken together, these data suggest that YC-1 enhances NK cell differentiation through the activation of p38 MAPK which is involved in NK cell differentiation.


Subject(s)
Cell Differentiation/drug effects , Enzyme Activators/pharmacology , Hematopoietic Stem Cells/drug effects , Indazoles/pharmacology , Killer Cells, Natural/drug effects , Blotting, Western , Cell Line, Tumor , Cyclic GMP/metabolism , Enzyme Inhibitors/pharmacology , Fetal Blood/cytology , Flow Cytometry , Humans , Imidazoles/pharmacology , Indazoles/antagonists & inhibitors , Phosphorylation , Pyridines/pharmacology , Receptors, Interleukin-15/drug effects , STAT5 Transcription Factor/biosynthesis , Signal Transduction/drug effects , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolism
14.
Immunol Lett ; 129(2): 78-84, 2010 Apr 08.
Article in English | MEDLINE | ID: mdl-20156484

ABSTRACT

The detailed mechanism driving the germinal center (GC) reaction to B cell lymphomagenesis has not been clarified. Thioredoxin interacting protein (TXNIP), also known as vitamin D3 up-regulated protein 1 which is an important tumor repressor, is involved in stress responses, redox regulation, and cellular proliferation. Here, we report that TXNIP has a potential role in the formation of GC in peripheral lymphoid organs where B lymphocytes divide rapidly. First, we compared changes in GC from wild type mice and Txnip(-/-) mice. After immunization, Txnip(-/-) mice exhibited higher expression level of BCL-6 and larger percentage of GC B cells with the reduction in antibody production and plasma cell numbers. In addition, Txnip(-/-) spleens had a much larger population which expressed Ki-67, a marker of cell proliferation, in the red pulp border than WT spleens. Furthermore, the expression of BCL-6 was decreased in TXNIP overexpressing cells and elevated in TXNIP deficient cells. Taken together, we conclude that TXNIP may contribute to the formation of GCs after immunization. During this process, TXNIP suppresses BCL-6 expression.


Subject(s)
B-Lymphocytes/immunology , Carrier Proteins/immunology , Down-Regulation , Germinal Center/cytology , Germinal Center/immunology , Proto-Oncogene Proteins c-bcl-6/immunology , Animals , Base Sequence , Blotting, Western , Cell Proliferation , Flow Cytometry , Immunohistochemistry , Male , Mice , Mice, Knockout , Molecular Sequence Data , Plasmids/genetics , Proto-Oncogene Proteins c-bcl-6/genetics
15.
J Immunol ; 183(12): 7931-8, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-19933860

ABSTRACT

Cross-linking of NK activating receptors activates phospholipase-gamma and subsequently induces diacylglycerol and Ca(2+) as second messengers of signal transduction. Previous studies reported that Ras guanyl nucleotide-releasing protein (RasGRP) 1, which is activated by diacylglycerol and Ca(2+), is crucial for TCR-mediated Ras-ERK activation. We now report that RasGRP1, which can also be detected in human NK cells, plays an essential role in NK cell effector functions. To examine the role of RasGRP1 in NK cell functions, the expression of RasGRP1 was suppressed using RNA interference. Knockdown of RasGRP1 significantly blocked ITAM-dependent cytokine production as well as NK cytotoxicity. Biochemically, RasGRP1-knockdown NK cells showed markedly decreased ability to activate Ras, ERK, and JNK. Activation of the Ras-MAPK pathway was independently shown to be indispensable for NK cell effector functions via the use of specific pharmacological inhibitors. Our results reveal that RasGRP1 is required for the activation of the Ras-MAPK pathway leading to NK cell effector functions. Moreover, our data suggest that RasGRP1 might act as an important bridge between phospholipase-gamma activation and NK cell effector functions via the Ras-MAPK pathway.


Subject(s)
DNA-Binding Proteins/physiology , Guanine Nucleotide Exchange Factors/physiology , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Cell Line, Tumor , DNA-Binding Proteins/deficiency , DNA-Binding Proteins/genetics , Fetal Blood/cytology , Fetal Blood/immunology , Fetal Blood/metabolism , Guanine Nucleotide Exchange Factors/deficiency , Guanine Nucleotide Exchange Factors/genetics , Humans , Intracellular Fluid/immunology , Intracellular Fluid/metabolism , K562 Cells , Killer Cells, Natural/pathology , Signal Transduction/genetics , Signal Transduction/immunology , Umbilical Cord/blood supply , Umbilical Cord/cytology , Umbilical Cord/immunology
16.
PLoS Pathog ; 5(8): e1000561, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19714221

ABSTRACT

Pseudomonas aeruginosa (PA) is an opportunistic pathogen that causes the relapse of illness in immunocompromised patients, leading to prolonged hospitalization, increased medical expense, and death. In this report, we show that PA invades natural killer (NK) cells and induces phagocytosis-induced cell death (PICD) of lymphocytes. In vivo tumor metastasis was augmented by PA infection, with a significant reduction in NK cell number. Adoptive transfer of NK cells mitigated PA-induced metastasis. Internalization of PA into NK cells was observed by transmission electron microscopy. In addition, PA invaded NK cells via phosphoinositide 3-kinase (PI3K) activation, and the phagocytic event led to caspase 9-dependent apoptosis of NK cells. PA-mediated NK cell apoptosis was dependent on activation of mitogen-activated protein (MAP) kinase and the generation of reactive oxygen species (ROS). These data suggest that the phagocytosis of PA by NK cells is a critical event that affects the relapse of diseases in immunocompromised patients, such as those with cancer, and provides important insights into the interactions between PA and NK cells.


Subject(s)
Apoptosis/immunology , Killer Cells, Natural/immunology , Phagocytosis/immunology , Pseudomonas aeruginosa/immunology , Animals , Caspase 9/immunology , Caspase 9/metabolism , Cell Line, Tumor , Cell Survival/physiology , Flow Cytometry , Humans , Immunohistochemistry , Killer Cells, Natural/metabolism , Killer Cells, Natural/microbiology , Melanoma/immunology , Melanoma/microbiology , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Neoplasm Metastasis , Neoplasm Transplantation , Phosphatidylinositol 3-Kinases/metabolism , Reactive Oxygen Species/metabolism
17.
J Immunol ; 183(4): 2495-505, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19625652

ABSTRACT

Hematopoietic stem cells (HSCs) are maintained in a quiescent state in bone marrow (BM) niches by intrinsic and extrinsic signals. The mechanisms regulating the quiescence and mobilization of HSCs, however, remain unclear. In this study, we report that the expression of thioredoxin-interacting protein (TXNIP) is decreased during HSC activation. In Txnip(-/-) mice, the long-term reconstituting HSC population is decreased and exhausted, and its capacity to repopulate is rapidly lost. These effects are associated with hyperactive Wnt signaling, an active cell cycle, and reduced p21 expression under conditions of stress. TXNIP deficiency reduced the CXCL12- and osteopontin-mediated interaction between HSCs and the bone marrow, and impaired homing and retention in the osteoblastic niche, resulting in mobilized HSCs. Therefore, we propose that TXNIP is essential for maintaining HSC quiescence and the interaction between HSCs and the BM niche.


Subject(s)
Carrier Proteins/physiology , Cell Movement/physiology , Hematopoietic Stem Cells/physiology , Resting Phase, Cell Cycle/physiology , Stress, Physiological , Thioredoxins/physiology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Bone Marrow Cells/physiology , Carrier Proteins/genetics , Cell Movement/genetics , Cells, Cultured , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Resting Phase, Cell Cycle/genetics , Signal Transduction/genetics , Stress, Physiological/genetics , Thioredoxins/genetics , Time Factors , Wnt1 Protein/antagonists & inhibitors , Wnt1 Protein/physiology
18.
Stem Cells ; 26(8): 2114-23, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18535152

ABSTRACT

The detailed mechanisms driving the development of natural killer (NK) cells from hematopoietic stem cells remain to be clearly elucidated. Here, we show that osteopontin (OPN) is a key factor for NK development. OPN-deficient mice evidenced severe impairments of NK development in bone marrow (BM) and spleen in which the NK populations that express CD122 and NK cell receptors were reduced. However, the absence of intrinsic OPN expression did not affect NK development, whereas the absence of OPN in the microenvironment caused a significant reduction in NK population. The expression of OPN was induced by interleukin (IL)-15 in BM stromal cells, and the defect in NK differentiation in IL-15(-/-) hematopoietic precursor cells (HPC) was recovered by addition of recombinant OPN, suggesting that the microenvironmental OPN may be a key factor in IL-15-mediated NK differentiation. In addition, OPN-driven NK maturation was reduced in T-bet-deficient HPC, suggesting that T-bet is required for OPN-mediated NK development. Collectively, these results show that paracrine OPN signaling drives NK-lineage commitment, thus ultimately promoting NK cell development. Disclosure of potential conflicts of interest is found at the end of this article.


Subject(s)
Gene Expression Regulation , Hematopoietic Stem Cells/cytology , Interleukin-15/biosynthesis , Killer Cells, Natural/cytology , Osteopontin/metabolism , T-Box Domain Proteins/metabolism , Animals , Bone Marrow Cells/cytology , Cell Differentiation , Interleukin-15/metabolism , Interleukin-2 Receptor beta Subunit/biosynthesis , Killer Cells, Natural/metabolism , Mice , Mice, Inbred C57BL , Models, Biological , Osteopontin/chemistry , Recombinant Proteins/chemistry , Spleen/metabolism
19.
Immunity ; 22(2): 195-208, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15723808

ABSTRACT

Vitamin D3 upregulated protein 1 (VDUP1) is a stress-response gene that is upregulated by 1,25(OH)2D3 in tumor cells. The in vivo roles of VDUP1 were investigated by producing mice lacking VDUP1 (VDUP1-/- mice). VDUP1-/- mice showed minimal changes in the development of T and B cells, but there was a profound reduction in the numbers of natural killer (NK) cells. As well, these mice showed decreased NK activity. In the VDUP1-/- mice, the expression of CD122 was reduced, demonstrating that VDUP1 is required for CD122 expression and NK maturation. In addition, severe lymphoid hyperplasia in the small intestine was observed in VDUP1-/- mice. Taken together, these results suggest that VDUP1 is a critical factor for the development and function of NK cells in vivo.


Subject(s)
Carrier Proteins/metabolism , Cell Differentiation , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Thioredoxins/metabolism , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Carrier Proteins/genetics , Carrier Proteins/immunology , Cell Line , Gene Deletion , Gene Expression Regulation , Humans , Hyperplasia/metabolism , Hyperplasia/pathology , Killer Cells, Natural/cytology , Mice , Mice, Knockout , Neoplasm Transplantation , Neoplasms/immunology , Neoplasms/metabolism , Receptors, Interleukin-2/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Thioredoxins/genetics , Thioredoxins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...